Last Sunday, CNN chief medical correspondent Sanjay Gupta, M.D., interviewed MAPS Founder Rick Doblin, Ph.D., and Acid Test author Tom Shroder about past and present research into the benefits of psychedelic-assisted psychotherapy. The interview can be viewed above.
Government-approved research is showing that psychedelic therapy can help people suffering from serious mental health conditions, especially those for whom other treatments have failed.
In just 16 days, MAPS’ crowdfunding campaign reached their $50,000 goal to complete funding for the largest-ever clinical trial of MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD), completing their multi-year, $1.38 million fundraising effort for this study. The results will help make MDMA-assisted psychotherapy the first legal psychedelic treatment by 2021.
All funds contributed above $50,000 will pay for costs associated with MAPS’ second-largest study of MDMA-assisted psychotherapy for PTSD, located in Boulder, Colorado. They still need $498,000 of the total cost of $711,000 to complete this study, which is now treating 23 subjects with PTSD from sexual assault, violent crime, war, natural disasters, or any other cause, and is an essential part of MAPS’ plan to make MDMA-assisted psychotherapy a legal treatment by 2021.
By making a donation and sharing this campaign, you help:
- Make MDMA-assisted psychotherapy a legal treatment by 2021
- Complete ongoing research into MDMA-assisted psychotherapy for PTSD from war, sexual assault, violent crime, or any other cause
- Demonstrate growing public support for psychedelic and medical marijuana research